Literature DB >> 12429615

Targeting multiple biological pathways as a strategy to improve the treatment of cancer.

Michael S O'Reilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12429615

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.

Authors:  Balamurali K Ambati; Emory Patterson; Pooja Jani; Crystal Jenkins; Eric Higgins; Nirbhai Singh; Tushar Suthar; Nehali Vira; Kimberly Smith; Ruth Caldwell
Journal:  Br J Ophthalmol       Date:  2006-12-06       Impact factor: 4.638

2.  Anti-cancer Activity of Centipeda minima Extract in Triple Negative Breast Cancer via Inhibition of AKT, NF-κB, and STAT3 Signaling Pathways.

Authors:  Magnolia Muk-Lan Lee; Brandon Dow Chan; Wing-Yan Wong; Zhao Qu; Man-Sum Chan; Tsz-Wing Leung; Yushan Lin; Daniel Kam-Wah Mok; Sibao Chen; William Chi-Shing Tai
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

3.  Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers.

Authors:  Timothy Crook; Darshana Patil; Andrew Gaya; Nicholas Plowman; Sewanti Limaye; Anantbhushan Ranade; Amit Bhatt; Raymond Page; Dadasaheb Akolkar
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

4.  Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy.

Authors:  Deepak Bhere; Nahid Arghiani; Esther Revai Lechtich; Yizheng Yao; Sarah Alsaab; Fengfeng Bei; Maryam M Matin; Khalid Shah
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.